Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion
Cellular Oncology（2024）
摘要
Despite chimeric antigen receptor (CAR) T-cell therapy has achieved great advances in recent year, approximately 50
更多查看译文
关键词
Chimeric antigen receptor T cell,Rituximab,r/r B-ALL
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要